The existing bifurcated regulatory framework, comprising the State Drug Control Departments (SDCD) and the Central Drugs Standard Control Organization (CDSCO), is fraught with inefficiencies and inconsistencies, undermining the effectiveness of drug regulation in India. The proposal to merge these entities into a single, unified Drug Regulatory System presents a comprehensive solution to these systemic shortcomings. This consolidation will ensure the uniform implementation of The Drugs & Cosmetics Act, 1940, and its associated rules, effectively addressing the prevalence of Not of Standard Quality (NSQ), spurious, and adulterated drugs. By centralizing regulatory oversight, the responsibility for ensuring drug quality in the domestic market and for exports will be streamlined and enhanced. Additionally, this integrated approach is poised to catalyze significant growth in the Indian pharmaceutical and allied industries, positioning them as global leaders in the near future